Drugs (Pharmaceuticals) – Page 59

China’s Abrupt Covid Pivot Leaves Many Without Medicines

Millions are desperate to get their hands on fever-reducing drugs and antivirals such as Pfizer’s Paxlovid as infections across China outpace supplies.

By David Pierson Isabelle Qian Olivia Wang and Tiffany May

Drug Resistance (Microbial) Drugs (Pharmaceuticals) Food and Drug Administration Hospitals Infections Law and Legislation Politics and Government Regulation and Deregulation of Industry United States Politics and Government

Can a Federally Funded ‘Netflix Model’ Fix the Broken Market for Antibiotics?

Shortages and drug-resistant germs have renewed attention on a $6 billion proposal in Congress that would reconfigure the way antimicrobial drugs are developed and sold.

By Andrew Jacobs

Biogen Inc Drugs (Pharmaceuticals) Eisai Co Ltd lecanemab New England Journal of Medicine Placebos Research

Alzheimer’s Drug May Benefit Some Patients, New Data Shows

The drug, lecanemab, made by Eisai and Biogen, also carried risks of brain swelling and bleeding and should be studied further, a report of the findings said.

By Pam Belluck

Children and Childhood Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Holidays and Special Occasions Hospitals Influenza Shortages Tamiflu (Drug)

Flu and R.S.V. Increase Demand for Antibiotics and Antivirals

An intense early flu season, coupled with a pediatric rise in respiratory illnesses, has left families frantically searching for medicines that are in short supply.

By Andrew Jacobs and Roni Caryn Rabin